Indications
Degenerative diseases of the joints and spine: osteoarthritis, osteochondrosis of the spine.
$42.00
Active ingredient: | |
---|---|
Dosage form: | |
Indications for use: |
Degenerative diseases of the joints and spine: osteoarthritis, osteochondrosis of the spine.
Inside, during or after a meal, with at least 1/2 cup of water.
Adults and adolescents from 15 years of age are prescribed 1 g / day (2 capsules 2 times a day).
The recommended duration of the initial course of treatment is 6 months, the period of action of the drug after its withdrawal is 3-5 months, depending on the localization and stage of the disease, the duration of repeated courses of treatment is set by the doctor.
-children under 15 years of age;
– hypersensitivity to the components of the drug Chondroitin-AKOS;
The drug should be used with caution in patients with bleeding and a tendency to bleeding, with thrombophlebitis.
1 capsule contains:
active ingredient:
chondroitin sodium sulfate 0.25 g,
excipients:
lactose (milk sugar);
calcium stearate
1 capsule contains:
Active ingredient:
chondroitin sodium sulfate 0.25 g,
excipients:
lactose (milk sugar);
calcium stearate
Stimulator of cartilage tissue regeneration (chondroprotector).
A high-molecular mucopolysaccharide derived from bovine tracheal cartilage.
It affects the metabolic processes in hyaline and fibrous cartilage, reduces degenerative changes in the cartilage tissue of joints, and stimulates the biosynthesis of glycosaminoglycans.
Promotes regeneration of the cartilage surfaces of joints and the articular bag, increases the production of intra-articular fluid. Slows down bone resorption and reduces calcium loss, accelerates the processes of bone recovery.
Treatment with Chondroitin-AKOS reduces pain and improves the mobility of the affected joints.
The therapeutic effect persists for a long time after the end of the course of treatment.
Degenerative diseases of the joints and spine: osteoarthritis, osteochondrosis of the spine.
The drug is not recommended to be prescribed during pregnancy and lactation due to the lack of sufficient clinical data.
— children under 15 years of age;- hypersensitivity to the components of the drug Chondroitin-AKOS;
The drug should be used with caution in patients with bleeding and a tendency to bleeding, with thrombophlebitis.
rarely — allergic reactions (urticaria, erythema, pruritus), nausea, vomiting.
with simultaneous use of the drug with other drugs, it is possible to increase the effect of indirect anticoagulants, antiplatelet agents, fibrinolytics.
Inside, during or after a meal, with at least 1/2 cup of water.
Adults and adolescents from 15 years of age are prescribed 1 g / day (2 capsules 2 times a day).
The recommended duration of the initial course of treatment is 6 months, the period of action of the drug after its withdrawal is 3-5 months, depending on the localization and stage of the disease, the duration of repeated courses of treatment is set by the doctor.
Symptoms: in rare cases, symptoms of overdose from the gastrointestinal tract are possible: nausea, vomiting, diarrhea; with prolonged use of excessively high doses (over 3 g/day), hemorrhagic rashes are possible.
Treatment: symptomatic.
should be used with caution in patients with bleeding (including in the anamnesis).
Capsules
Store in a dry place, protected from light, at a temperature not exceeding 20 °C
3 years
Chondroitin sulfate
Capsules
For children over 15 years of age, For adults as prescribed by a doctor, For Children as prescribed by a doctor
Osteoarthritis, Osteoarthritis, Osteochondrosis, Arthritis
Reviews
There are no reviews yet